Concord Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Cash & Equivalents	151.42	34.99	6.67	51.44	24.08
Short-Term Investments	228.22	305.8	872.5	550	-
Trading Asset Securities	2,437	1,369	734.73	1,410	1,981
Cash & Short-Term Investments	2,817	1,710	1,614	2,011	2,005
Cash Growth	64.71%	5.96%	-19.76%	0.31%	-
Accounts Receivable	3,496	2,738	2,322	1,775	1,835
Other Receivables	159.99	217.95	272.74	358.19	133.64
Receivables	3,656	2,956	2,594	2,133	1,969
Inventory	2,080	2,123	1,951	1,536	1,112
Prepaid Expenses	73.31	55.19	47.61	45.44	40.23
Other Current Assets	336.73	433.05	119.5	345.27	259.47
Total Current Assets	8,962	7,277	6,327	6,071	5,386
Property, Plant & Equipment	7,865	7,655	6,436	5,577	3,809
Long-Term Investments	20.7	79.25	2.56	3.66	8.15
Other Intangible Assets	3.2	1.98	35.77	64.18	0.93
Other Long-Term Assets	156.1	126.8	327.4	108.69	201.1
Total Assets	17,007	15,140	13,128	11,825	9,405
Accounts Payable	944.35	938	831.06	463.97	712.33
Accrued Expenses	168.21	146.19	131.45	102.38	75.61
Short-Term Debt	-	-	43.37	50.99	-
Current Portion of Long-Term Debt	62.3	250	250	250	125
Current Portion of Leases	16.21	1.47	15.96	13.01	10.91
Current Income Taxes Payable	54.94	89.99	-	-	17.82
Current Unearned Revenue	-	13.13	32.72	-	-
Other Current Liabilities	175.55	479.67	247.1	177.04	209.28
Total Current Liabilities	1,422	1,918	1,552	1,057	1,151
Long-Term Debt	-	62.36	312.49	562.5	355.28
Long-Term Leases	18.87	1.64	3.11	16.33	29.35
Long-Term Deferred Tax Liabilities	280.65	234.39	209.71	174.53	151.29
Other Long-Term Liabilities	19.56	22.97	18.74	20.98	15.94
Total Liabilities	1,741	2,240	2,096	1,832	1,703
Common Stock	104.62	104.62	95.11	95.11	95.11
Additional Paid-In Capital	819.71	819.71	829.22	829.22	829.22
Retained Earnings	14,342	11,976	10,108	9,069	6,778
Shareholders' Equity	15,266	12,900	11,032	9,994	7,702
Total Liabilities & Equity	17,007	15,140	13,128	11,825	9,405
Total Debt	97.38	315.46	624.93	892.83	520.54
Net Cash (Debt)	2,719	1,395	988.98	1,118	1,485
Net Cash Growth	94.98%	41.02%	-11.58%	-24.66%	-
Net Cash Per Share	25.99	13.33	9.45	10.69	14.19
Filing Date Shares Outstanding	104.62	104.62	104.62	104.62	104.62
Total Common Shares Outstanding	104.62	104.62	104.62	104.62	104.62
Working Capital	7,541	5,359	4,775	5,014	4,235
Book Value Per Share	145.93	123.31	105.45	95.53	73.62
Tangible Book Value	15,263	12,898	10,996	9,930	7,701
Tangible Book Value Per Share	145.90	123.29	105.11	94.91	73.62
Land	547.11	547.11	547.11	546.99	543.41
Buildings	2,576	2,463	2,226	1,981	735.36
Machinery	4,979	4,788	4,285	3,773	1,776
Construction In Progress	2,115	1,727	741.55	179.46	1,414

Source: S&P Global Market Intelligence. Standard template. Financial Sources.